Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 6/20 | 0.48 |
| ▸ | TGM2 | P21980 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.47 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.44 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31189388 | 0.85 | TDP1 (0.45) | TDP1ALDH1A1ENPP2PTGS2TGM2 | |
| SCHEMBL103783 | 0.80 | ALDH1A1 (0.58) | TDP1ALDH1A1PTGS2TGM2 | |
| SCHEMBL9720721 | 0.80 | MAOB (0.55) | ALDH1A1ENPP2PTGS2AKR1C3AKR1C2 | |
| SCHEMBL177953 | 0.80 | TDP1 (0.67) | TDP1ALDH1A1 | |
| SCHEMBL9720723 | 0.80 | MAOB (0.55) | ALDH1A1ENPP2PTGS2AKR1C3AKR1C2 | |
| SCHEMBL2376239 | 0.79 | ENPP2 (0.72) | ENPP2PTGS2 | |
| SCHEMBL1202375 | 0.78 | ENPP2 (0.52) | ALDH1A1ENPP2PTGS2AKR1C3AKR1C2 | |
| SCHEMBL19276537 | 0.78 | ALDH1A1 (0.55) | TDP1ALDH1A1 | |
| SCHEMBL607349 | 0.78 | ENPP2 (0.52) | ALDH1A1ENPP2PTGS2AKR1C3AKR1C2 | |
| SCHEMBL27592527 | 0.78 | TDP1 (0.64) | TDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11220062-B2 | Water-dispersible thermoplastic material comprising sulfonated copolymer for use in additive manufacturing | STRATASYS, INC. (US) | 2022-01-11 | — | — | US | claimed |
| US-20200207025-A1 | WATER-DISPERSIBLE THERMOPLASTIC MATERIAL COMPRISING SULFONATED COPOLYMER FOR USE IN ADDITIVE MANUFACTURING | STRATASYS, INC. | 2020-07-02 | — | — | US | claimed |
| EP-4294800-B1 | APOL1 INHIBITORS AND METHODS OF USE | MAZE THERAPEUTICS INC (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4539840-A1 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-119730846-A | Kinase modulators and methods of use thereof | 神经元23公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-119176645-B | Sea water desalination method and sea water desalination system | 杭州水处理技术研究开发中心有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-119176645-A | Sea water desalination method and sea water desalination system | 杭州水处理技术研究开发中心有限公司 | 2024-12-24 | — | — | CN | disclosed |
| WO-2024249252-A1 | METHODS OF USING APOL1 INHIBITORS | MAZE THERAPEUTICS, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| US-20240316038-A1 | APOL1 INHIBITORS AND METHODS OF USE | HERCULES CAPITAL, INC., AS AGENT | 2024-09-26 | — | — | US | disclosed |
| WO-2023244788-A9 | KINASE MODULATORS AND METHODS OF USE THEREOF | NEURON23, INC. (US) | 2024-09-12 | — | — | WO | disclosed |
| US-20240191087-A1 | WATER DISPERSIBLE SULFONATED THERMOPLASTIC COPOLYMER FOR USE IN ADDITIVE MANUFACTURING | STRATASYS INC (US) | 2024-06-13 | — | — | US | disclosed |
| US-20040204421-A1 | Certain 1,3-disubstituted isoquinoline derivatives | EISAI CO., LTD. | 2004-10-14 | — | — | US | disclosed |
| US-6790844-B2 | MUSCLE RELAXANTS; ANTISEROTONINE AGENT | EISAI CO., LTD (JP) | 2004-09-14 | — | — | US | disclosed |
| US-20020013460-A1 | Condensed pyridine compound | EISAI CO., LTD | 2002-01-31 | — | — | US | disclosed |
| US-6340759-B1 | ANTISPASMODIC AGENTS | EISAI CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| EP-1020445-A1 | FUSED PYRIDINE DERIVATIVES | Eisai Co., Ltd. (JP) | 2000-07-19 | — | — | EP | disclosed |
| EP-0570932-B1 | Styrenic block copolymer and process for producing same | IDEMITSU KOSAN CO (JP) | 1997-07-23 | — | — | EP | disclosed |
| US-5418290-A | Compatability with other resins, adhesion | IDEMITSU KOSAN CO., LTD. (JP) | 1995-05-23 | — | — | US | disclosed |
| US-5391626-A | Syndiotactic, high performance, compatibility and adhesiveness; molding materials | IDEMITSU KOSAN CO., LTD. (JP) | 1995-02-21 | — | — | US | disclosed |
| EP-0570932-A2 | Styrenic block copolymer and process for producing same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013460-A1 | Condensed pyridine compound | MUSK, HTR1A, PAX3 | TDP1 1197/4885ALDH1A1 2989/4885ENPP2 4029/4885 |
| US-20040204421-A1 | Certain 1,3-disubstituted isoquinoline derivatives | MUSK, HTR1A, RYR1 | TDP1 326/4885ALDH1A1 1071/4885ENPP2 4088/4885 |
| US-20240316038-A1 | APOL1 INHIBITORS AND METHODS OF USE | APOL1, SAAL1, APOB | TDP1 760/4885ALDH1A1 1839/4885ENPP2 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.